Read + Share
Amedeo Smart
Independent Medical Education
Qin XY, Shirakami Y, Honda M, Yeh SH, et al. Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence. Int J Cancer 2024 Feb 21. doi: 10.1002/ijc.34893.PMID: 38380807
Email
LinkedIn
Facebook
Twitter
Privacy Policy